Why is Kopran Ltd ?
- PBT LESS OI(Q) At Rs 25.26 cr has Grown at 141.72%
- OPERATING PROFIT TO INTEREST(Q) Highest at 10.39 times
- NET SALES(Q) Highest at Rs 234.02 cr
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 13.90%, its profits have fallen by -33.3%
- The stock has generated a return of 13.90% in the last 1 year, much higher than market (BSE500) returns of 2.91%
How much should you buy?
- Overall Portfolio exposure to Kopran should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kopran for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 25.26 cr has Grown at 141.72%
Highest at 10.39 times
Highest at Rs 234.02 cr
Highest at Rs 32.95 cr.
Highest at 14.08%
Highest at Rs 18.87 cr.
Highest at Rs 3.91
At Rs 18.29 cr has Grown at -33.39%
Lowest at Rs 7.22 cr
Lowest at 2.59 times
Highest at Rs 3.17 cr
Here's what is working for Kopran
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Operating Profit to Interest
Net Sales (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
EPS (Rs)
Here's what is not working for Kopran
Interest Paid (Rs cr)
Cash and Cash Equivalents
Debtors Turnover Ratio






